Etomethazene
Etomethazene (5-methyldesnitroetonitazene, 5-methyl etodesnitazene, Eto) is a benzimidazole derivative with opioid effects which has been sold as a designer drug over the internet since 2022, first being definitively identified in Sweden…
≈ 1 min read
Etomethazene. encyclopegia.org, snapshot enwiki-001361898123. /a/etomethazene
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Etomethazene (5-methyldesnitroetonitazene, 5-methyl etodesnitazene, Eto) is a benzimidazole derivative with opioid effects which has been sold as a designer drug over the internet since 2022, first being definitively identified in Sweden in January 2023. It is an analogue of etonitazene where the nitro (NO 2 ) group has been replaced by a methyl (CH 3 ) group.
It is less potent than etonitazene itself but still has around twice the potency of fentanyl. Etomethazene has a relatively short duration of action of about 120 min.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1361898123 under CC BY-SA 4.0; modifications have been made.